Detail page

Knowledge Web

Person

Markus Zeitlinger (1975-)

Pharmakologe

Name	Markus Zeitlinger
Time	1975- (Date of birth and death)
Place	Wien (Wirkungsort) Österreich
Gender	männlich
Academic degree	Prof. Dr. med.
Profession	Pharmakologe (characteristic profession) Arzt Hochschullehrer
Variant	M. Zeitlinger
Related	Universitätsklinik für Klinische Pharmakologie (Wien) (Privatdozent)
Source	https://www.meduniwien.ac.at/hp/phd-immunologie/research-laboratories/researcher-details/?res=markus_zeitlinger (Stand: 14.02.2024) OBV: https://permalink.obvsg.at/AC16157048 (Stand:20.05.2021)
Record type	Person
GND-Identifier	1233797263
Record ID	1233797263
Involved in show all Challenges in assessing the immunization status of adults in Germany—lessons from a population-based VACCELERATE survey on polio vaccination Advancing 6-bromo-7-[11C]methylpurine to clinical use: improved regioselective radiosynthesis, non-clinical toxicity data and human dosimetry estimates Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors Pulmonary surfactant impacts in vitro activity of selected antifungal drugs against Candida krusei and Candida albicans Impact of Key Components of Intensified Ceftaroline Dosing on Pharmacokinetic/Pharmacodynamic Target Attainment Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical Data Community-acquired and hospital-acquired bacterial co-infections in patients hospitalized with Covid-19 or influenza: a retrospective cohort study Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial Pilot Pharmacokinetic Study in Healthy Adults Using Intravascular Microdialysis Catheters Modified for Use in Paediatric Patients to Assess Vancomycin Blood Levels Microdialysis of Voriconazole and its N-Oxide Metabolite: Amalgamating Knowledge of Distribution and Metabolism Processes in Humans Microdialysis of Drug and Drug Metabolite: a Comprehensive In Vitro Analysis for Voriconazole and Voriconazole N-oxide Perception of clinical research among patients and healthy volunteers of clinical trials Biomarkers Predicting Tissue Pharmacokinetics of Antimicrobials in Sepsis: A Review Microdosing as a Potential Tool to Enhance Clinical Development of Novel Antibiotics: A Tissue and Plasma PK Feasibility Study with Ciprofloxacin Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies Comparative plasma and interstitial tissue fluid pharmacokinetics of meropenem demonstrate the need for increasing dose and infusion duration in obese and non-obese patients Tigecycline soft tissue penetration in obese and non-obese surgical patients determined by using in vivo microdialysis Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients Comparison of non-invasive Staphylococcus aureus sampling methods on lesional skin in patients with atopic dermatitis Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [11C]Metoclopramide Similar piperacillin/tazobactam target attainment in obese versus nonobese patients despite differences in interstitial tissue fluid pharmacokinetics Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antibacterial Agents: A Review Brain Exposure to Piperacillin in Acute Hemorrhagic Stroke Patients Assessed by Cerebral Microdialysis and Population Pharmacokinetics From St. John’s wort to tomato and from Rhodiola to cranberry : A review of phytotherapy and some examples Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents Linezolid concentrations in plasma and subcutaneous tissue are reduced in obese patients, resulting in a higher risk of underdosing in critically ill patients: a controlled clinical pharmacokinetic study Meropenem plasma and interstitial soft tissue concentrations in obese and nonobese patients — a controlled clinical trial Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography Impact of thrombocytes, on bacterial growth and antimicrobial activity of selected antibiotics Impact of different antimycotics on cytokine levels in an in vitro aspergillosis model in human whole blood Prospective evaluation of the performance of [68Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy A population pharmacokinetic model of intravenous telavancin in healthy individuals to assess tissue exposure Advancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14–16, 2018; Vienna, Austria Comment on “Target-Controlled Continuous Infusion for Antibiotic Dosing: Proof-of-Principle in an In-silico Vancomycin Trial in Intensive Care Unit Patients” Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid Impact of erythrocytes on bacterial growth and antimicrobial activity of selected antibiotics Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa Clinical Pharmacokinetics and Pharmacodynamics of Telavancin Compared with the Other Glycopeptides Pharmacokinetics of doripenem in plasma and epithelial lining fluid (ELF): comparison of two dosage regimens Colistin dampens fibrinolysis and endothelial activation during endotoxaemia : A randomised, double blind trial Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients Pilot Investigation on Long-Term Subcutaneous Microdialysis: Proof of Principle in Humans A PET microdosing study with the P-glycoprotein inhibitor tariquidar Characterization of colistin tissue pharmacokinetics by microdialysis [11C]Elacridar as a novel P-glycoprotein PET tracer, assessment of whole-body distribution and radiation dosimetry in humans A combined accelerator mass spectrometry/positron emission tomography microdose study to assess the plasma and brain tissue pharmacokinetics of 11C- and 14C-labelled verapamil in healthy volunteers In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Markus Zeitlinger (1975-)

Challenges in assessing the immunization status of adults in Germany—lessons from a population-based VACCELERATE survey on polio vaccination

Advancing 6-bromo-7-[11C]methylpurine to clinical use: improved regioselective radiosynthesis, non-clinical toxicity data and human dosimetry estimates

Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors

Pulmonary surfactant impacts in vitro activity of selected antifungal drugs against Candida krusei and Candida albicans

Impact of Key Components of Intensified Ceftaroline Dosing on Pharmacokinetic/Pharmacodynamic Target Attainment

Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical Data

Community-acquired and hospital-acquired bacterial co-infections in patients hospitalized with Covid-19 or influenza: a retrospective cohort study

Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers

Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial

Pilot Pharmacokinetic Study in Healthy Adults Using Intravascular Microdialysis Catheters Modified for Use in Paediatric Patients to Assess Vancomycin Blood Levels

Microdialysis of Voriconazole and its N-Oxide Metabolite: Amalgamating Knowledge of Distribution and Metabolism Processes in Humans

Microdialysis of Drug and Drug Metabolite: a Comprehensive In Vitro Analysis for Voriconazole and Voriconazole N-oxide

Perception of clinical research among patients and healthy volunteers of clinical trials

Biomarkers Predicting Tissue Pharmacokinetics of Antimicrobials in Sepsis: A Review

Microdosing as a Potential Tool to Enhance Clinical Development of Novel Antibiotics: A Tissue and Plasma PK Feasibility Study with Ciprofloxacin

Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies

Comparative plasma and interstitial tissue fluid pharmacokinetics of meropenem demonstrate the need for increasing dose and infusion duration in obese and non-obese patients

Tigecycline soft tissue penetration in obese and non-obese surgical patients determined by using in vivo microdialysis

Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients

Comparison of non-invasive Staphylococcus aureus sampling methods on lesional skin in patients with atopic dermatitis

Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [11C]Metoclopramide

Similar piperacillin/tazobactam target attainment in obese versus nonobese patients despite differences in interstitial tissue fluid pharmacokinetics

Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey

Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents

Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antibacterial Agents: A Review

Brain Exposure to Piperacillin in Acute Hemorrhagic Stroke Patients Assessed by Cerebral Microdialysis and Population Pharmacokinetics

From St. John’s wort to tomato and from Rhodiola to cranberry : A review of phytotherapy and some examples

Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents

Linezolid concentrations in plasma and subcutaneous tissue are reduced in obese patients, resulting in a higher risk of underdosing in critically ill patients: a controlled clinical pharmacokinetic study

Meropenem plasma and interstitial soft tissue concentrations in obese and nonobese patients — a controlled clinical trial

Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography

Impact of thrombocytes, on bacterial growth and antimicrobial activity of selected antibiotics

Impact of different antimycotics on cytokine levels in an in vitro aspergillosis model in human whole blood

Prospective evaluation of the performance of [68Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy

A population pharmacokinetic model of intravenous telavancin in healthy individuals to assess tissue exposure

Advancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14–16, 2018; Vienna, Austria

Comment on “Target-Controlled Continuous Infusion for Antibiotic Dosing: Proof-of-Principle in an In-silico Vancomycin Trial in Intensive Care Unit Patients”

Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography

Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions

In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid

Impact of erythrocytes on bacterial growth and antimicrobial activity of selected antibiotics

Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration

Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa

Clinical Pharmacokinetics and Pharmacodynamics of Telavancin Compared with the Other Glycopeptides

Pharmacokinetics of doripenem in plasma and epithelial lining fluid (ELF): comparison of two dosage regimens

Colistin dampens fibrinolysis and endothelial activation during endotoxaemia : A randomised, double blind trial

Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients

Pilot Investigation on Long-Term Subcutaneous Microdialysis: Proof of Principle in Humans

A PET microdosing study with the P-glycoprotein inhibitor tariquidar

Characterization of colistin tissue pharmacokinetics by microdialysis

[11C]Elacridar as a novel P-glycoprotein PET tracer, assessment of whole-body distribution and radiation dosimetry in humans

A combined accelerator mass spectrometry/positron emission tomography microdose study to assess the plasma and brain tissue pharmacokinetics of 11C- and 14C-labelled verapamil in healthy volunteers

In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET